SY-4798

N/A

Report date: 2025/11/06 15:39:25
NME

Base Information

Drug NameSY-4798
Drug Alias NameSY-4798
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 4 antagonists
TargetsFibroblast growth factor receptor 4
Therapy Area/IndicationsSolid tumoursBiliary Tract NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShouyao Holding (Beijing) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShouyao Holding (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursBiliary Tract NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A